These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 316688)

  • 1. Quantification of HTLA-positive lymphocytes during oral photochemotherapy of psoriasis.
    Schmitt D; Ortonne JP; Alario A; Thivolet J
    Arch Dermatol Res; 1979 Nov; 266(3):227-231. PubMed ID: 316688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient impairment of peripheral blood lymphocyte function during PUVA therapy.
    Morison WL; Parrish JA; Bloch KJ; Krugler JI
    Br J Dermatol; 1979 Oct; 101(4):391-7. PubMed ID: 315786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T lymphocyte E rosette function during photochemotherapy (PUVA) of psoriasis.
    Haftek M; Gliński W; Jabłońska S; Obałek S
    J Invest Dermatol; 1979 May; 72(5):214-8. PubMed ID: 313426
    [No Abstract]   [Full Text] [Related]  

  • 4. Antinuclear antibodies and oral methoxsalen photochemotherapy (PUVA) for psoriasis.
    Stern RS; Morison WL; Thibodeau LA; Kleinerman RA; Parrish JA; Geer DE; Fitzpatrick TB
    Arch Dermatol; 1979 Nov; 115(11):1320-4. PubMed ID: 389166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photochemotherapy of psoriasis (PUVA).
    Rosten M
    N Z Med J; 1979 Aug; 90(641):101-2. PubMed ID: 290909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of oral PUVA therapy for psoriasis.
    J Am Acad Dermatol; 1979 Aug; 1(2):106-17. PubMed ID: 521510
    [No Abstract]   [Full Text] [Related]  

  • 7. Topical methoxsalen photochemotherapy in the treatment of palmoplantar pustulosis and psoriasis.
    Wilkinson JD; Ralfs IG; Harper JI; Black MM
    Acta Derm Venereol Suppl (Stockh); 1979; 59(85):193-8. PubMed ID: 393036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 8-methoxypsoralen plus UVA (PUVA) on lymphocyte transformation and T cells in psoriatic patients.
    Fräki JE; Eskola J; Hopsu-Havu VK
    Br J Dermatol; 1979 May; 100(5):543-50. PubMed ID: 312653
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experience with the photochemotherapy of psoriasis in Lausanne (author's transl)].
    Frenk E; Perroud H
    Dermatologica; 1978; 157(5):292-3. PubMed ID: 680303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Methoxypsoralen (Bergapten) in photochemotherapy of psoriasis.
    Hönigsmann H; Jaschke E; Gschnait F; Brenner W; Fritsch P; Wolff K
    Br J Dermatol; 1979 Oct; 101(4):369-78. PubMed ID: 508604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte proliferation during PUVA therapy.
    Lischka G
    Arch Dermatol Res; 1979 Jun; 265(2):213-8. PubMed ID: 464663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of PUVA treatment on circulating lymphocytes.
    Clayton R; Valdimarsson H; Fry L
    Br J Dermatol; 1979 Feb; 100(2):225-6. PubMed ID: 427023
    [No Abstract]   [Full Text] [Related]  

  • 13. [Double-blind studies on the effect of topical PUVA therapy for psoriasis. Supplement: open controlled studies on the effect of topical PUVA and topical steroid therapy for psoriasis. (author's transl)].
    Mizuno N
    Nihon Hifuka Gakkai Zasshi; 1980 Mar; 90(4):313-32. PubMed ID: 6991736
    [No Abstract]   [Full Text] [Related]  

  • 14. Toxic hepatitis from oral methoxsalen photochemotherapy (PUVA).
    Pariser DM; Wyles RJ
    J Am Acad Dermatol; 1980 Sep; 3(3):248-50. PubMed ID: 7451691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oral 8-methoxypsoralen-UVA (PUVA) therapy in psoriasis: comparison of 3 treatment protocols].
    Hofmann C; Neiss A; Plewig G; Braun-Falco O
    Hautarzt; 1980 Jun; 31(6):315-23. PubMed ID: 6893320
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis.
    Stern RS; Thibodeau LA; Kleinerman RA; Parrish JA; Fitzpatrick TB
    N Engl J Med; 1979 Apr; 300(15):809-13. PubMed ID: 423919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin typing for assessment of skin cancer risk and acute response to UV-B and oral methoxsalen photochemotherapy.
    Stern RS; Momtaz K
    Arch Dermatol; 1984 Jul; 120(7):869-73. PubMed ID: 6732259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photochemotherapy of psoriasis using methoxsalen and sunlight. A controlled study.
    Parrish JA; White AD; Kingsbury T; Zahar M; Fitzpatrick TB
    Arch Dermatol; 1977 Nov; 113(11):1529-32. PubMed ID: 337903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal T-lymphocyte function in psoriatic patients undergoing methoxsalen photochemotherapy.
    Harper RA; Tam DW; Vonderheid EC; Urbach F
    J Invest Dermatol; 1979 Jun; 72(6):323-5. PubMed ID: 312888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of lymphocytes in patients with psoriasis under photochemotherapy. A study of lymphocyte transformation.
    Wassilew SW
    Arch Dermatol Res; 1978 Nov; 263(2):127-34. PubMed ID: 736599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.